We have patented technologies, with extensive clinical trials, that show how IntraLymphNode Allergen ImmunoTherapy (IL-AIT) can eliminate allergy symptoms for years.
We are currently raising funds to launch the AlleCures™ platform in the USA. We will be looking to expand our US clinical trials for specific allergens. We believe the AlleCure™ Platform could eliminate sensitivity to common allergens.
AlleCures is a spinout of Colby Pharmaceuticals. The AlleCures™ platform is based on years of international clinical studies and research. We are committed to creating safe treatment for allergies and developing innovative solutions for medical professionals.